• Wepfer Award 2010

The "Johann Jacob Wepfer Award" of the European Stroke Conference honors scientists for their outstanding scientific work in the field of cerebrovascular diseases and significant contributions to our knowledge about treatment of acute stroke.
This award was dedicated yesterday to:

Prof. J. van Gijn, The Netherlands - Congratulations!!!

Please find more information on facebook: http://www.facebook.com/pages/esc-european-stroke-conference/338806502734
and on the
european stroke conference blog: http://europeanstrokeconference.wordpress.com/

 

Webcasts from the J.J. Wepfer Award 2010

Websast: Presentation of the winner
P. Sandercock, UK

Webcast: J.J.Wepfer Lecture
J. van Gijn, The Netherlands

Results of the "CREST"  trial

We are pleased to communicate that the results of the CREST study presented by A.Mackey et al. during the LARGE CLINICAL TRIAL SESSION II on Friday 28-5-2010 11.30-11.40  in the European Stroke Conference will be published in the NEJM simultaneously. Please use the following links  free of charge:

Article: http://content.nejm.org/cgi/content/full/NEJMoa0912321

Editorial: http://content.nejm.org/cgi/content/full/NEJMe1005220

Results of the "ACES" trial

Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study
Hugh S Markus, Alice King, Martin Shipley, Raffi Topakian, Marisa Cullinane, Sheila Reihill, Natan M Bornstein, Arjen Schaafsma
Reprinted with permission from Elsevier (The Lancet Neurology, 2010. Published online May 28, 2010. DOI:10.1016/S1474-4422(10)70120-4).
The Lancet:  http://www.lancet.com/journals/laneur/issue/current
Please download the pdf file here!(pdf 431 kb)

Webcasts from the Educational Symposium I 

Atrial fibrillation – New avenues in diagnosis and treatment

Chairs: M.G. Hennerici, Germany and J.-L. Mas, France
Please follow the links!

Webcast: Introduction
M.G. Hennerici, Germany

Webcast: Asymtomatic atrial fibrillation
E. Aliot, France

Webcast: Rhythm control versus rate control
J.Y Le Heuzey, France

Webcast: Interventional treatments of AF: evidence for benefit
E.M. Aliot, France

Webcast: Antithrombotic treatments in AF: the beginning of the end for vitamin K antagonists?
H.-C. Diener, Germany
Conclusion
J.-L. Mas, France

Webcasts from the oral session: Large clinical trials (RCTs) B
Chairs: S. Davis, Australia and N. Wahlgren, Sweden
Please follow the links

 The Randomized Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST): results by symptomatic status
A.Mackey, Hop de L'Enfant Jesus, Quebec City, CANADA

The Asymptomatic Carotid Emboli Study (ACES): Do Doppler embolic signals predict stroke and TIA risk in asymptomatic carotid stenosis? First resultsThe Asymptomatic Carotid Emboli Study (ACES): Do Doppler embolic signals predict stroke and TIA risk in asymptomatic carotid stenosis? First results
H.S.Markus, St George's University of London, London, UNITED KINGDOM

Prospective meta-analysis of individual patient data from three randomised trials of stenting versus endarterectomy for symptomatic carotid stenosis: Short-term outcomeProspective meta-analysis of individual patient data from three randomised trials of stenting versus endarterectomy for symptomatic carotid stenosis: Short-term outcome
L.H.Bonati, Department of Neurology, University Hospital Basel, Basel, SWITZERLAND

The efficacy and safety of 10% dextran 40 in the prevention of stroke complicating carotid endarterectomy – the Dextran In Carotid Endarterectomy (DICE) trial.
C.R.Levi, University of Newcastle and Hunter Medical Research Institute, Newcastle, AUSTRALIA

The Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): Main Results
T.G.Robinson, University of Leicester, Leicester, UNITED KINGDOM

 

Webcasts from the  ESC/ESO Symposium
(European Stroke Conference/ European Stroke Organisation)
Chairs: P. Michel, Switzerland and V. Caso, Italy

TIA should be treated in TIA clinics, not admitted to stroke units
Chair: J. Ferro, Portugal
Webcast:Pro: P. Amarenco, France
Webcast:Contra: C.L. Sudlow, UK
PFO: Close high risk patients vs. never close
Chair: D. Thaler, USA
Webcast:Pro: K. Muir, UK
Webcast:Contra: J.L. Mas, France
Should patients with unknown time window be treated with rtPA?
Chair: P. Michel, Switzerland
Webcast Pro: P. Schellinger, Germany
Webcast: Contra A. Davalos, Spain

 

 Webcast from the Special Stroke Lecture

 Webcast: Amyloid, Hypertension and Cognitive Dysfunction
C. Iadecola, USA